by TS Potpara 2024 Cited by 32eliminated, no CKD-related dose adjustments was required in near- ly 30% of centres, whilst in 26.8% of centres amiodarone was used with caution in patients
by CA Jackevicius 2024 Cited by 70and CKD were significantly higher in the user group. Con- versely, age low-dose amiodarone. Circ J 2024;10 –1616. 15. Rakita L, Sobol SM
dose of amiodarone. While amiodarone is effective in rhythm control chronic kidney disease (CKD) into ESRD. - Sympathetic Nervous
amiodarone will depend on the dose of amiodarone IV dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Type of drug: gamma aminobutyric acid (GABA) analogue Use: itching in CKD; chronic pain; epilepsy Dose: in CKD, start low dose, e.g. 100mg
CKD stages (Table 4). The proportion of patients on antiarrhythmic therapy receiving amiodarone increased with worsening renal function (P
Type of drug: gamma aminobutyric acid (GABA) analogue Use: itching in CKD; chronic pain; epilepsy Dose: in CKD, start low dose, e.g. 100mg
Precise vancomycin dosing is important to maximize treatment success in patients with CKD. Yet CKD alters vancomycin pharmacokinetics, making precise dosing a challenge. We report the derivation, validation, and postimplementation evaluation of a vancomycin dosing application (VancApp) for optimizing dosing decisions in patients with CKD.
by M Thind 2024 Cited by 1While amiodarone is a potent AAD, it can cause serious thyroid chronic kidney disease (CKD). AF rates are particularly high in
Comments